DA-3934

• Description:

  DA-3934 is a cholecystokinin (CCK) -B receptor antagonist. DA-3934 inhibits Pentagastrin (HY-A0261) -induced gastric acid secretion in rats[1].

• UNSPSC:

  12352005

• Target:

  Cholecystokinin Receptor

• Type:

  Reference compound

• Related Pathways:

  GPCR/G Protein; Neuronal Signaling

• Field of Research:

  Neurological Disease

• Assay Protocol:

  https://www.medchemexpress.com/da-3934.html

• Smiles:

  CN(C(COC1=C(N(CC(N(C2=CC=CC=C2)C)=O)C(CNC(NC3=CC=CC(CC(O)=O)=C3)=O)=O)C=CC=C1)=O)C4=CC=CC=C4

• Molecular Formula:

  C35H35N5O7

• Molecular Weight:

  637.68

• References & Citations:

  [1]Takeda Y, et al. Synthesis of phenoxyacetic acid derivatives as highly potent antagonists of gastrin/cholecystokinin-B receptors. II. Chem Pharm Bull (Tokyo) . 1998 Jun;46 (6) :951-61.

• Shipping Conditions:

  Room temperature

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported

• CAS Number:

  [183176-50-3]